Posts Tagged ‘violence’

More About Psychiatric Drugs Causing Violence and Suicide

Monday, July 22nd, 2019

Reference:

Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family
by Yolande Lucire and Christopher Crotty
Pharmacogenomics and Personalized Medicine, 1 August 2011
[doi: 10.2147/PGPM.S17445]

This research paper details patients who had been referred to Dr. Lucire’s practice for expert opinion or treatment. More than 120 subjects were diagnosed with akathisia [a neurotoxic psychosis often characterized by a feeling of inner restlessness and inability to stay still] or serotonin toxicity [extremely high levels of serotonin causing toxic and potentially fatal effects] after taking psychiatric drugs that had been prescribed for psychosocial distress. Akathisia has been known to be associated with suicide since the 1950s and with homicide since 1985.

They were tested for variant alleles in cytochrome P450 (CYP450) genes, which play a major role in the metabolism of all antidepressant and many other drugs, indicating ultrarapid metabolism due to allele duplications. This seems to be strongly associated with a large number of deaths from intoxication and suicide. High or fast-changing levels of psychotropic substances can cause unpredictable toxicity leading to violent behavioral effects, including akathisia. [An allele is one of two or more alternative forms of a gene that arise by mutation and are found at the same place on a chromosome.]

Psychiatric drugs are metabolized in the liver by cytochrome P450 enzymes in order to be eliminated from the body. Abnormal CYP450 metabolism, either ultrarapid and/or diminished, can lead to the drug or its metabolites reaching a toxic level in hours or days, correlating with the onset of intense dysphoria [unease or generalized dissatisfaction with life] and akathisia. A person genetically deficient in these enzymes, or who has an ultrarapid drug metabolism, or who is taking other (legal or illegal) drugs that diminish CYP450 enzyme activity, is at risk of a toxic accumulation of the drug leading to more severe side effects.

Eight of these cases had committed homicide and many more became extremely violent or suicidal while on antidepressants. Ten representative case histories involving serious violence are presented in great detail in the paper. None of the ten subjects described had any history of mental illness; none had been violent before. All recovered from akathisia after stopping the medication without assistance or supervision and, frequently, against medical advice.

Akathisia suicides and homicides, particularly when they involved children, gave rise to the first antidepressant suicide advisories by the FDA in 2004.

Personal, medical, and legal problems can arise from using psychiatric drugs and experiencing the resulting toxicity from these metabolic effects. The results presented in this paper demonstrate the grave extent to which the psychiatric industry has expanded its influence beyond its ability to cure.

As the authors state, “In all of the cases presented here, the subjects were prescribed antidepressants that failed to mitigate distress emerging from their predicaments, which encompassed psychosocial stressors such as bereavement, marital and relationship difficulties, and work-related stress. Every subject’s emotional reaction worsened while their prescribing physicians continued the “trial and error” approach, increasing from standard to higher dose and/or switching to other antidepressants, with disastrous consequences. In some cases the violence ensued from changes occasioned by withdrawal and polypharmacy. In all of these cases, the subjects were put into a state of drug-induced toxicity manifesting as akathisia, which resolved only upon discontinuation of the antidepressant drugs.”

“It is the authors’ contention that prescribing antidepressants without knowing about CYP450 genotypes is like giving blood transfusions without matching for ABO groups [the classification of human blood].”

In general, the psychiatric industry pushes psychotropic drugs without regard to these CYP450 cautions, but this is the direct result of the unscientific psychiatric diagnoses perpetrated by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) which fraudulently justifies prescribing these harmful drugs for profit in the first place.

Recommendations

1. Practice Full Informed Consent by asking your doctor for information about possible side effects and benefits, ways to treat side effects, and risks of other conditions, as well as information about alternative treatments.

2. If your doctor diagnoses a mental disorder and prescribes a psychiatric drug, ask to see the clinical lab tests proving the diagnosis. (There won’t be any.)

3. All treatment options should include checking for real underlying medical conditions that could cause a patient’s mental or emotional duress.

4. Write your state and federal legislators to establish rights for patients and their insurance companies to receive refunds for mental health treatment which did not achieve the promised result or improvement, or which resulted in proven harm to the individual, thereby ensuring that responsibility lies with the individual practitioner and psychiatric facility rather than the government or its agencies.

5. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5), psychiatry’s billing manual for mental disorders, is the key to false escalating mental illness statistics and psychiatric drug prescriptions and usage worldwide. Untold harm and colossal waste of mental health funds occur because of it. It is imperative that the DSM diagnostic system be abandoned before real mental health reform can occur.

6. Patients, doctors and insurance companies should report all instances of adverse side effects from psychiatric drugs to the FDA.

7. The pernicious influence of psychiatry has wreaked havoc throughout society, especially in hospitals, educational systems and prisons. Citizens groups and responsible government officials should work together to expose and abolish psychiatry’s hidden manipulation of society for profit.

Psychiatric Inpatients Have Elevated Risks for Adverse Reactions

Monday, July 1st, 2019

[Reference: “Multiple adverse outcomes following first discharge from inpatient psychiatric care: a national cohort study”, The Lancet Psychiatry, June 03, 2019]

People discharged from inpatient psychiatric care are at higher risk than the rest of the population for a range of serious fatal and non-fatal adverse outcomes.

These individuals are also more likely to perpetrate violent crimes, including homicide. Suicide risk is known to be especially raised soon after discharge.

Results were summarized from 62,922 Danish people who had been discharged from inpatient psychiatric services and 1,573,050 who had never been a psychiatric inpatient, examining these adverse outcomes over ten years post-discharge: mortality, suicide, accidental death, homicide victimization, homicide perpetration, non-fatal self-harm, violent criminality, and hospitalization following violence.

The risk of at least one of these adverse outcomes was highest in people using psychoactive drugs.

Although no detailed clinical information was available regarding what psychiatric treatments were given, it can be assumed that psychiatric (psychoactive) drugs were a major part of most treatments, since worldwide statistics show that a rapidly increasing percentage of every age group, from children to the elderly, rely heavily and routinely on psychiatric drugs in their daily lives. Worldwide sales of antidepressants, for example, were more than $14 billion in 2017, and expected to surpass $15 billion by 2023.

These statistics give one more result in a long line of significant research that concludes:

  • psychiatry cannot cure any so-called mental illness
  • psychiatric treatments cause violence and suicide
  • psychiatric treatments actually harm rather than help vulnerable people
  • psychiatry is junk science
  • psychiatric drugs can only chemically mask problems and symptoms; they cannot and never will be able to solve problems

People in desperate circumstances must be provided proper and effective medical care. Medical, not psychiatric, attention, good nutrition, a healthy, safe environment and activity that promotes confidence will do far more than the brutality of psychiatry’s treatments.

While life is full of problems, and sometimes those problems can be overwhelming, it is important for you to know that psychiatry, its diagnoses and its drugs are the wrong way to go.

Mental Health in St. Louis

Saturday, June 8th, 2019

A new report (“St. Louis Regional Mental Health Data Report“, May, 2019) outlines mental health trends in the St. Louis, Missouri region.

The St. Louis County Department of Public Health and the City of St. Louis Department of Health prepared the report for System of Care St. Louis Region.

One significant finding is that “…intentional self-harm (i.e., suicide) was the sixth leading cause of death for children under 18 years of age and the third leading cause of death for ages 18 to 24 years in St. Louis County, and it is the tenth leading cause of death for all age groups in both the United States and the state of Missouri.”

Unfortunately, the report fails to notice that there is overwhelming evidence that psychiatric drugs cause suicide and violence.

While there is never one simple explanation for what drives a human being to commit such unspeakable acts of violence, all too often one common denominator has surfaced in hundreds of cases—-prescribed psychiatric drugs which are documented to cause mania, psychosis, violence, suicide and in some cases, homicidal ideation. To date, there has been no federal investigation of the link between psychiatric drugs and acts of suicide and violence.

Mental disorder is not a predictor of aggressive behavior, but rather the adverse effects of the drugs prescribed to treat it. Drug proponents argue that there are many shootings and acts of violence that have not been correlated to psychiatric (psychotropic) drugs, but that is exactly the point. It has neither been confirmed nor refuted, as law enforcement is not required to investigate or report on prescribed drugs linked to suicide and violence, and media rarely pose the question.

Those with a vested, financial interest will continue to champion the use of such drugs, as the psychiatric-pharmaceutical drug industry rakes in an average of $35 billion a year in sales in the U.S. alone. It is that vested financial interest which may be preventing a thorough investigation of the link between prescription psychoactive drugs and increased suicide and violence, especially considering that there have been calls for such investigations since the Columbine High School massacre in 1999.

The theory that a person is violent because he “stopped taking his medication” is misleading and omits the fact that it is more likely to be the withdrawal from a drug of dependence that is experienced—-not the return of the person’s “untreated mental illness.” Numerous studies and expert opinions support this. Psychotropic drug withdrawal destroys mental faculties and creates impulsivity.

It is long past time that government agencies answered that call with an investigation. Legislative hearings should be held to fully investigate the correlation between psychiatric treatment and violence and suicide. None can argue against the fact that disclosure of the facts would serve the public interest.

Click here for more information about the link between suicide, violence, and psychiatric drugs.

Hear This — Zone Out on Zonisamide

Saturday, March 23rd, 2019

The March 15-21, 2019 issue of the St. Louis Business Journal noted a $10.5 million Army grant to the Washington University in St. Louis Medical School to study the epilepsy drug Zonisamide to see if it could prevent hearing loss from loud noises. This seemed like such an imaginative stretch that we decided to look into it in more detail.

The justification given is that Zonisamide is conjectured to protect hearing loss when given ahead of exposure to loud noises. We wondered how this came about. We also note that other epilepsy drugs are psych-related, so we wondered if there was a psych drug connection here as well.

In a rat study, researchers proposed using a substance that blocks calcium channels to see if it could prevent hearing loss against loud noises. Zonisamide also blocks calcium channels. Gee, maybe Zonisamide can prevent hearing loss.

Zonisamide is the generic name used in the United States for a seizure drug whose common brand name is Zonegran. It was first used in Japan in the early 1970’s to treat so-called psychiatric disorders, and has been used off-label by psychiatrists in the U.S. as a mood stabilizer. The FDA approved it for seizures in 2000, although it is totally unknown as to how it works to prevent seizures. The FDA notes that taking this drug may increase the risk of depression, psychosis and suicidal thoughts or actions.

Using Zonisamide during pregnancy may present a significant risk to the fetus due to the possibility of birth defects.

Zonisamide was first studied in Japan in the 1970’s during exploratory research on drugs for psychiatric disorders. The drug alters the concentration of dopamine in the brain, but is apparently dosage dependent — that is, different dosages can increase or decrease dopamine concentrations, leading to unpredictable results.

Zonisamide is metabolized in the liver by Cytochrome P450 enzymes, so its side effects can be magnified in those persons with a genetic lack of these enzymes.

Typically we see that the psychiatric research community makes a guess about re-purposing some old drug so it can be re-used for a new patient population, guesses how it might work in the rat brain, then guesses how it might work in the human brain, each time asking for more funding to make further guesses, eventually leading to the FDA approving a new use for an old drug even though they still don’t know how it “works.”

While medicine has advanced on a scientific path to major discoveries and cures, psychiatry has never evolved scientifically and is no closer to understanding or curing mental problems, thus must continually seek to find new uses for old treatments.

While medicine has nurtured an enviable record of achievements and general popular acceptance, the public still links psychiatry to snake pits, straitjackets, and “One Flew Over the Cuckoo’s Nest.” Psychiatry continues to foster that valid impression with its development of such brutal treatments as ECT, psychosurgery, the chemical straitjacket caused by antipsychotic drugs, and its long record of treatment failures including Zonisamide as a mood stabilizer.

In over 40 years, “biological psychiatry” has yet to validate a single psychiatric condition/diagnosis as an abnormality/disease, or as anything neurological, biological, chemically imbalanced or genetic.

The drugs prescribed for psychiatric conditions, such as using Zonisamide as a mood stabilizer, only exacerbate the conditions they are supposed to treat. And when these drugs are used for other non-psychiatric conditions, they continue having the same adverse reactions, such as depression and suicide when Zonisamide is used for epilepsy. It will have the same adverse reactions if it is ever used for hearing loss. And they will still not know how it “works.”

We suggest that funding only be provided for workable medical treatments that dramatically improve and cure health and mental health problems. For more information, download and read the CCHR booklet “Psychiatric Hoax – The Subversion of Medicine – Report and recommendations on psychiatry’s destructive impact on health care.

Knock Yourself Out with Spravato (Esketamine)

Monday, March 18th, 2019

A nasal spray version of the anesthetic drug ketamine was approved by the FDA on March 5, 2019 for treatment-resistant depression.

Janssen Pharmaceuticals says that the cost for a one-month course of treatment for Spravato (generic esketamine) will be between $4,720 and $6,785.

Esketamine is the S-enantiomer of ketamine, which means that it is one of the two mirror images of the chemical structure of ketamine, S (for the Latin sinister) being the left image. It enhances glutamine release in the brain. Glutamine is an amino acid used in the synthesis of proteins, among other things. In the brain, glutamine is used in the production of neurotransmitters. It is believed that glutamine plays a role in raising or lowering aggression levels.

Treatment requires that doses be taken, in conjunction with an oral antidepressant, in a doctor’s office or clinic, with patients monitored for at least two hours, and their experience entered in a registry.

Because of the risk of serious adverse outcomes and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system. At least you can’t take it home with you.

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug.

Basically, it knocks you out so you don’t feel so depressed anymore. You don’t feel much of anything, actually, since you’ve just taken an anesthetic in the snout.

There were four phase 3 clinical trials; two of them failed to show any statistical improvement, but the drug was approved anyway because it was on the Fast Track and Breakthrough Therapy paths.

A 9/5/2018 update from Consumer Reports said, “All these drugs [Ketamine, Phenylbutazone, Chloramphenicol] are prohibited in beef, poultry, and pork consumed in the U.S. Yet government data obtained by Consumer Reports suggest that trace amounts of these and other banned or severely restricted drugs may appear in the U.S. meat supply more often than was previously known.”

Note that “depression” is not an actual medical illness; it is simply a symptom of some undiagnosed and untreated condition. A diagnosis of depression is a prime example of psychiatric fraud.

Any form of ketamine used to treat so-called depression is unethical and harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Go here for more information about alternatives to drugs.

Rexulti Fails to Get Results

Monday, November 26th, 2018

REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in 2015 as an atypical antipsychotic and prescribed for the fake “disease” schizophrenia.

Then in 2018 the FDA approved it to treat symptoms of depression when antidepressants alone do not relieve symptoms.

The cost for Rexulti oral tablet 0.25 mg is around $1,166 for a supply of 30 tablets. It has similarities to Abilify, and apparently it was developed to replace Abilify when that drug’s patent expired in 2014.

Brexpiprazole affects the levels of the neurotransmitters dopamine and serotonin in the brain. It is thought to reduce dopamine output when dopamine concentrations are high and increase dopamine output when dopamine concentrations are low. It also activates serotonin receptors to increase serotonin levels in a manner thought to reduce hallucinogenic effects, which is a problem with all drugs that mess with serotonin in the brain.

The metabolism of the drug — that is, the mechanism which eventually eliminates it from the body — is mediated by Cytochrome P450 enzymes; people who are known poor metabolizers, i.e. those with a genetic lack of these enzymes, should be instructed to take half the usual dose, although this is rarely done, since the patient must first be tested for this genetic condition. It is estimated that 10% of Caucasians and 7% of African Americans are Cytochrome P450 deficient. The consequences for someone with this deficiency who takes this drug are an increased risk for the accumulation of the non-metabolized drug in the body and the resultant increase in adverse side effects such as depression, violence and suicide.

Drugs like Rexulti can raise the risk of death in the elderly, and it is not approved for the treatment of patients with dementia-related psychosis. This drug may also increase suicidal thoughts or actions in some children, teenagers, or young adults within the first few months of treatment. It is not approved for the treatment of people younger than 18 years of age.

Rexulti may cause other serious side effects, including: compulsive, uncontrollable behaviors such as gambling, shopping, binge eating and sex (the same as with Abilify); stroke in elderly people; Neuroleptic Malignant Syndrome; high fever; stiff muscles; confusion; sweating; changes in pulse, heart rate, or blood pressure; high blood sugar (hyperglycemia); weight gain; seizures; difficulty swallowing; uncontrolled body movements known as tardive dyskinesia. Tardive dyskinesia may not go away, even after one stops taking the drug, and tardive dyskinesia may also start some time after one stops taking the drug.

The real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous. Find Out! Fight Back!

More About Dopamine

Sunday, November 11th, 2018

Since we discussed Serotonin in a previous newsletter, we should also discuss Dopamine.

Dopamine is a neurotransmitter that plays several important roles in the brain and body. A neurotransmitter is a chemical released by neurons (nerve cells) to send signals to other nerve cells. Its chemical formula is C8H11NO2. It belongs to a family of chemicals with high psychoactive properties.

Dopamine was first synthesized in 1910, first identified in the human brain in 1957, and its function as a neurotransmitter was first recognized in 1958. The name comes from a contraction of chemicals in its synthesis.

The anticipation of rewards increases the level of dopamine in the brain, and many addictive drugs increase dopamine release or block its reuptake into neurons following release.

Dopamine has other effects around the body:

  • helps widen blood vessels
  • helps increase urine output
  • helps regulate insulin production
  • helps to protect the gastrointestinal tract
  • helps control motor function
  • helps regulate aggression

Because it seems to be involved in the anticipation of rewards, it is seen as a chemical of pleasure or happiness. Most antipsychotic drugs are dopamine antagonists which reduce dopamine activity. Decreased levels of dopamine have also been associated with painful symptoms. Like serotonin, dopamine levels must be strictly regulated since both an excess and a deficiency can be problematic.

Side effects of dopamine include lowered kidney function and irregular heartbeats, addiction, and an overdose can be fatal. Cocaine, methamphetamine, Adderall, Ritalin, Concerta, MDMA (ecstasy) and other psychostimulants generally increase dopamine levels in the brain by a variety of mechanisms.

Dopamine and serotonin are both neurotransmitters; an imbalance of either one can have disastrous effects on health, mental health, digestion, sleep cycle, and so on. The serotonergic system has strong anatomical and functional interactions with the dopaminergic system. While they both affect a lot of the same parts of the body, they do so in distinct ways which are still not fully understood. In the brain in general, dopamine is an excitatory neurotransmitter and serotonin is an inhibitory neurotransmitter. The imbalance of these two chemicals can cause a number of disorders; thus, drugs which mess with either of these play Russian roulette with your brain.

Because both serotonin and dopamine are involved in regulating aggression in different ways, one can see that imbalances can lead to suicidal thoughts and behaviors, which is a common side effect of drugs which mess with these neurotransmitters.

Researchers still only conjecture about any relationship between mental symptoms and dopamine, and they are coming to understand that the results do not support the hype.

Psychiatrists have known since the beginning of psychopharmacology that their drugs do not cure any disease. Further, there is no credible evidence that mental health is genetic or linked to dopamine transport; these are just public relations theories to support the marketing and sale of drugs. The manufacturers of every such drug state in the fine print that they don’t really understand how it works. Psychiatric drugs are fraudulently marketed as safe and effective for the sole purpose of earning billions for the psycho-pharmaceutical industry.

These drugs mask the real cause of problems in life and debilitate the individual, so denying him or her the opportunity for real recovery and hope for the future. This is the real reason why psychiatry is a violation of human rights. Psychiatric treatment is not just a failure — it is routinely destructive to the individual and one’s mental health.

Mental Health, Social Justice and Education

Sunday, August 26th, 2018

 

Social Justice: Fair and just relations between the individual and society, assigning rights and duties in the institutions of society, so that people receive basic societal benefits in return for their cooperation and participation.

 

In the Health Care field, social justice often means affordable access to ethical and effective health care.

In the field of Human Rights, we defer to the Universal Declaration of Human Rights, adopted by the United Nations General Assembly in 1948.

In Mental Health Care, we promote the Mental Health Declaration of Human Rights. All human rights organizations set forth codes by which they align their purposes and activities. The Mental Health Declaration of Human Rights articulates the guiding principles of CCHR and the standards against which human rights violations by psychiatry are relentlessly investigated and exposed. Under the banner of the Mental Health Declaration of Human Rights, tens of thousands of people around the globe have joined CCHR and taken to the streets to protest psychiatric drugging and other inhumane mental health practices.

Through stigmatizing labels, unscientific diagnoses, easy seizure commitment laws and brutal, depersonalizing “treatments,” thousands around the world suffer under psychiatry’s coercive system every day. It is a system that exemplifies human rights abuse. Modern psychiatry still has no scientific veracity and knows and admits it, but keeps up the charade for the sake of profit.

By depicting those they label mentally ill as a danger to themselves or others, psychiatrists have convinced governments and courts that depriving such individuals of their liberty, is mandatory for the safety of all concerned. Wherever psychiatry has succeeded in this campaign, extreme abuses of human rights have resulted.

One of CCHR’s primary concerns with psychiatry is its unscientific diagnostic system. Unlike medical diagnosis, psychiatrists categorize symptoms only, not disease. The Diagnostic and Statistical Manual of Mental Disorders (DSM–5) published by the American Psychiatric Association is notorious for low scientific validity.

Understanding this fraudulent diagnostic premise, we can see why psychiatry and psychology, entrusted with billions of dollars to eradicate the problems of the mind, have created and perpetuated them. Their drug panaceas cause senseless acts of violence, suicide, sexual dysfunction, irreversible nervous system damage, hallucinations, apathy, irritability, anxiousness, psychosis and death. And with virtually unrestrained psychiatric drugging of so many of our schoolchildren, it is no surprise that the largest age group of murderers today are our 15–to–19–year–olds.

Mental Health, Social Justice, and the Educational System

Drugging children with addictive, violence-causing mind-altering psychotropic drugs is the “social justice” currently being employed by the psychiatric mental health industry. The rationale is, the drugged kids will now be able to compete with children from wealthier families who attend better schools. Rutgers psychiatrist Ramesh Raghavan, formerly at Washington University in St. Louis, chillingly said, “We are effectively forcing local community psychiatrists to use the only tool at their disposal [to ‘level the playing field’ in low-income neighborhoods], which is psychotropic medicine.”

The whole basis for this “social justice” program in low-income communities—that the ADHD drugs will improve school performance of kids and “level the playing field,” so they can compete academically with children from wealthier families—this whole program is based on a lie to begin with.

Meddling with the brains of children via these chemicals constitutes criminal assault, and it’s time it was recognized for what it is.

CCHR believes that everyone has the right to full informed consent regarding psychiatric drugs and other psychiatric treatments. Find out more by clicking here.

Crime and Mental Distress

Saturday, July 7th, 2018

A recent news report suggests that “Having a mental illness makes people more vulnerable to becoming the victims of a crime.”

We wondered about this, because it sounds just like the incessant and inane psychobabble coming out of the “psychology today” brain mill.

These results are suspicious because the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) lists “Victim of crime” as a mental disorder. So it’s hard to imagine that both “mental illness causes being a victim of crime” and “being a victim of crime causes mental illness.” It’s a no-win situation, and the fact that the DSM is a fraudulent machine used to sell psychiatric drugs does not make it more palatable.

The DSM-5 also has fourteen other diagnoses about being a victim in various abusive situations, and thirteen diagnoses about being the perpetrator of abuse or violence. It would seem that both victims and perpetrators are the focus of a lot of attention; so many ways to prescribe psychiatric drugs known to cause violence.

The study authors are using these questionable results to assert that people with mental illness are more likely to be victims rather than perpetrators of crime, giving the benefit of doubt to those who commit violence and further contributing to the perception of the “dangerous environment” so necessary to the existence of coercive psychiatry.

They are trying to prove that school shooters are not mentally ill, because this taint goes against the massive psychiatric public relations campaign to “stop the stigma of mental illness,” which is really a campaign underwritten by pharmaceutical companies to sell drugs.

The fact is, the real criminals here are psychiatrists and psychologists.

The soaring crime rate began to rise when psychiatrists and psychologists infiltrated the fields of education and law. When you put criminals in charge of crime, the crime rate rises.

If psychiatrists and psychologists actually knew what they were doing, the crime rate would drop. Instead, they conduct sham research about the relationship between crime and mental illness, instead of actually curing people and cementing the safety and security of society.

Real criminals would want to obfuscate the issues and point the finger away from themselves. Guess what? When the criminal mind accuses others, he is likely disclosing his own type of crime. And the fact is, psychiatric drugs cause violence, proven again and again as psych-drug-addled school shooters rage on.

Criminals think everyone else is a criminal, since they cannot envision people being decent. Psychiatrists and psychologists, focusing their attention on crime and illness, fail to observe human decency, and think there is nothing else but crime, deceit, and violence — all to be suppressed with harmful and addictive drugs, electroshock, psycho-surgery, involuntary incarceration, and restraints.

Recommendations

1. Legislative hearings should be held to fully investigate the correlation between psychiatric treatment and violence and suicide.

2. Toxicology testing for psychiatric and even illicit drugs should be mandatory in cases where someone has committed a mass shooting or other serious violent crime.

3. Train law enforcement officers, school security and teachers in the adverse effects of psychotropic drugs in order to recognize that irrational, violent and suicidal behavior in persons they may face could be influenced by these drugs.

4. No student shall be forced to take any psychotropic drug as a requisite of their education, in alignment with Title 20 of United States Code: Chapter 33, “Education of Individuals with Disabilities,” Subchapter II, (25) “Prohibition on mandatory medication.”

Psychiatric Drugs, School Violence, and Big Pharma Cover-Up

Monday, July 2nd, 2018

A study published June 12, 2018 from the University of Illinois at Chicago suggests that more than one-third (37.2%) of U.S. adults may be using prescription drugs that have the potential to cause depression or increase the risk of suicide.
[JAMA. 2018;319(22);2289-2298. doi:10.1001/jama.2018.6741]

Information about more than 26,000 adults from 2005 to 2014 was analyzed, along with more than 200 commonly prescribed drugs. However, many of these drugs are also available over the counter, so these results may underestimate the true prevalence of drugs having side effects of depression.

In other words, the use of prescription drugs, not just psychiatric drugs, that have depression or suicide as a potential adverse reaction is fairly common, and the more drugs one takes (called polypharmacy), the greater the likelihood of depression occurring as a side effect. “The likelihood of concurrent depression was most pronounced among adults concurrently using 3 or more medications with depression as a potential adverse effect, including among adults treated with antidepressants.”

Approximately 15% of adults who used three or more of these drugs concurrently experienced symptoms of depression or suicidal thoughts, compared with just 5% for those not using any of these drugs. Roughly 7.6% of adults using just one of these drugs reported a side effect of depression or suicidal thoughts during the study period, and 9% for those using two of these drugs. These results were the same whether the drugs were psychotropic or not. Depression was determined by asking nine questions related to the symptoms defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

“Commonly used depression screening instruments, however, do not incorporate evaluations of prescribed medications that have depression as a potential adverse effect.” In other words, so-called depression screening tests can register false positives when the person is taking one or more of roughly 200 prescription drugs.

We thought we should dig a little deeper into this phenomenon.

First, understand that there is no depression “disease”. A person can certainly have symptoms of feeling depressed, but this is not a medical condition in itself. An example of a medical condition with a symptom of depression would be a vitamin B1 (thiamine) deficiency. You don’t fix it with an antidepressant; you fix it with vitamin B1. There are hundreds of medical conditions that may have mental symptoms, just as there are hundreds of drugs that can cause or worsen these symptoms. Finding the actual causes with appropriate clinical tests and then fixing what is found is the correct way to proceed.

This leads to a topic known as CYP450, which stands for Cytochrome P450 enzymes. Cytochrome means “cellular pigment” and is a protein found in blood cells. Scientists understand these enzymes to be responsible for metabolizing almost half of all drugs currently on the market, including psychiatric drugs.

These are the major enzymes involved in drug metabolism, which is the breakdown of drugs in the liver or other organs so that they can be eliminated from the body once they have performed their function.

If these drugs are not metabolized and eliminated once they have done their work, they build up and become concentrated in the body, and then act as toxins. The possibility of harmful side effects, or adverse reactions, increases as the toxic concentration increases. The ballpark estimate is that each year 2.2 million Americans are hospitalized for adverse reactions and over 100,000 die from them.

Some people are deficient in CYP450 or have diminished capacity to metabolize these drugs, which may be a genetic or other issue. Individuals with no or poorly performing CYP450 enzymes are much more likely to suffer the side effects of prescription drugs, particularly psychiatric drugs known to have side effects of depression, violence and suicide.

These metabolic processes are immature at birth and up to three years old, and this may result in an increased risk for drug toxicity in infants and young children. Furthermore, certain drugs or certain excipients in vaccines may inhibit activation of CYP450 enzymes, again resulting in an increased risk for the accumulation of non-metabolized drugs and the resultant increase in adverse side effects such as depression, violence and suicide.

The side effects caused by a CYP450 deficiency and its subsequent failure to metabolize any one of hundreds of drugs can then be misdiagnosed as a mental illness, the patient then being prescribed more psychiatric drugs in a mistaken attempt to treat those side effects, further complicating the problems.

It is estimated that 10% of Caucasians and 7% of African Americans are Cytochrome P450 deficient.

The psychiatric and pharmaceutical industries have been aware of this phenomenon for some time, yet they have continued to push psychiatric drugs at an ever increasing rate, and the dramatic increase in symptoms of depression, suicide, and school violence is a direct result.

No one should be prescribed these types of drugs without adequate testing for a CYP450 deficiency, in order to determine their risk potential for adverse reactions. The test is not “standard of care” so one has to ask for it; but beware, they will still recommend an alternative drug if the original one cannot be easily metabolized. Better yet, stop prescribing all psychiatric drugs and find out with proper medical, clinical tests what the real problems are and treat those. Full informed consent is always indicated.

Any psychiatrist or pharmaceutical company that has knowingly withheld evidence about the relationship between CYP450 enzymes and drug side effects should be subject to both prosecution and litigation.

Medical students should be educated about these relationships.

For more information click on any of the links in this newsletter.